Making decisions about benefits and harms of medicines
- PMID: 15231628
- PMCID: PMC443458
- DOI: 10.1136/bmj.329.7456.47
Making decisions about benefits and harms of medicines
Abstract
Even when good scientific data are available, people's interpretation of risks and benefits will differ
Figures


Comment in
-
Balancing benefits and harms in health care: ethical dimension was not discussed in theme issue.BMJ. 2004 Aug 21;329(7463):458; discussion 458-9. doi: 10.1136/bmj.329.7463.458. BMJ. 2004. PMID: 15321912 Free PMC article. No abstract available.
Comment on
-
Detection, verification, and quantification of adverse drug reactions.BMJ. 2004 Jul 3;329(7456):44-7. doi: 10.1136/bmj.329.7456.44. BMJ. 2004. PMID: 15231627 Free PMC article. Review.
References
-
- Bastani B, Alphs LD, Meltzer HY. Development of the clozaril patient management system. Psychopharmacology (Berl) 1989;99(suppl): S122-5. - PubMed
-
- Mayer EA, Bradesi S. Alosetron and irritable bowel syndrome. Expert Opin Pharmacother 2003;4: 2089-98. - PubMed
-
- Ances BM. New concerns about thalidomide. Obstet Gynecol 2002;99: 125-8. - PubMed
-
- Berwick DM. The total customer relationship in health care: broadening the bandwidth. Joint Commission Journal on Quality Improvement 1997;23: 245-50. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical